Bristol Myers Squibb (BMY) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$10.6 billion.
- Bristol Myers Squibb's Enterprise Value rose 153.62% to -$10.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$10.6 billion, marking a year-over-year increase of 153.62%. This contributed to the annual value of -$10.6 billion for FY2025, which is 153.62% up from last year.
- Bristol Myers Squibb's Enterprise Value amounted to -$10.6 billion in Q4 2025, which was up 153.62% from -$16.5 billion recorded in Q3 2025.
- Over the past 5 years, Bristol Myers Squibb's Enterprise Value peaked at -$6.6 billion during Q2 2024, and registered a low of -$16.9 billion during Q4 2021.
- Its 5-year average for Enterprise Value is -$11.5 billion, with a median of -$11.3 billion in 2024.
- In the last 5 years, Bristol Myers Squibb's Enterprise Value surged by 4560.51% in 2022 and then plummeted by 10531.9% in 2025.
- Bristol Myers Squibb's Enterprise Value (Quarter) stood at -$16.9 billion in 2021, then skyrocketed by 45.61% to -$9.2 billion in 2022, then crashed by 32.94% to -$12.2 billion in 2023, then rose by 11.61% to -$10.8 billion in 2024, then increased by 1.54% to -$10.6 billion in 2025.
- Its Enterprise Value stands at -$10.6 billion for Q4 2025, versus -$16.5 billion for Q3 2025 and -$13.5 billion for Q2 2025.